CTisus Pancreas Compendium 对比 RadCS 的使用情况和统计数据

This Application presents a complete analysis of pancreatic tumors by: 1. using a checklist to better define the etiology of a pancreatic mass in a systematic fashion with a detailed and proven pathway. 2. reviewing & select cases from the teaching file of over 2000 pathologically proven cases across a range of pancreatic pathologies. 3. reviewing a series of pearls on various pancreatic lesions. 4. listening to lectures about pancreatic tumors including lectures on solid and cystic pancreatic lesions. 5. reviewing a series of illustrations about pancreatic anatomy and surgeries used for management of pancreatic tumors. 6. review a series of quiz cases to test your ability at arriving at the correct diagnosis.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

This app RadCS has been created for at-hand look up of or as a mini-textbook for important measurements and numbers that we commonly use in radiology practice. Editor-in-chief Dr. Shyam Sabat. Contributors: Dr. Dhanashree Rajdekar, Dr. Abdullah M., Dr. Andrew Blum, Dr. Troy Storey, Dr. Cooper Dean, and others). DISCLAIMER: Versive Inc, developers of the app, have no independent medical expertise and make no claims as to the veracity of this content. The Board Certified sub-specialty radiologists creating the app have extensive medical expertise, and update this app whenever information or direction is known to change. Notwithstanding, all users of this app, medical professionals or otherwise are fully responsible for their use or application of information contained herein. The contents are intended to be used for educational purposes only and the authors/editors do not claim copyright over the contents.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

CTisus Pancreas Compendium与RadCS排名比较

对比 CTisus Pancreas Compendium 与 RadCS 在过去 28 天内的排名趋势

排名

没有可用的数据

CTisus Pancreas Compendium 对比 RadCS 的排名,按国家/地区比较

对比 CTisus Pancreas Compendium 与 RadCS 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
CTisus Pancreas Compendium VS.
RadCS

十二月 18, 2024